Inari Medical Past Earnings Performance

Past criteria checks 0/6

Inari Medical's earnings have been declining at an average annual rate of -67.9%, while the Medical Equipment industry saw earnings growing at 12.5% annually. Revenues have been growing at an average rate of 36.9% per year.

Key information

-67.9%

Earnings growth rate

-65.0%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate36.9%
Return on equity-18.1%
Net Margin-13.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Inari Medical, Inc. (NASDAQ:NARI) Stocks Shoot Up 31% But Its P/S Still Looks Reasonable

Nov 07
Inari Medical, Inc. (NASDAQ:NARI) Stocks Shoot Up 31% But Its P/S Still Looks Reasonable

Investors Interested In Inari Medical, Inc.'s (NASDAQ:NARI) Revenues

Sep 23
Investors Interested In Inari Medical, Inc.'s (NASDAQ:NARI) Revenues

Inari Medical: A Touch Of Uncertainty And Overvaluation

Jul 05

At US$43.23, Is It Time To Put Inari Medical, Inc. (NASDAQ:NARI) On Your Watch List?

Jun 18
At US$43.23, Is It Time To Put Inari Medical, Inc. (NASDAQ:NARI) On Your Watch List?

Market Participants Recognise Inari Medical, Inc.'s (NASDAQ:NARI) Revenues Pushing Shares 26% Higher

May 23
Market Participants Recognise Inari Medical, Inc.'s (NASDAQ:NARI) Revenues Pushing Shares 26% Higher

Is Inari Medical, Inc. (NASDAQ:NARI) Trading At A 29% Discount?

May 02
Is Inari Medical, Inc. (NASDAQ:NARI) Trading At A 29% Discount?

Inari Medical: Buy On Growing TAM

Mar 27

Why We're Not Concerned Yet About Inari Medical, Inc.'s (NASDAQ:NARI) 25% Share Price Plunge

Mar 08
Why We're Not Concerned Yet About Inari Medical, Inc.'s (NASDAQ:NARI) 25% Share Price Plunge

Is Now The Time To Look At Buying Inari Medical, Inc. (NASDAQ:NARI)?

Dec 14
Is Now The Time To Look At Buying Inari Medical, Inc. (NASDAQ:NARI)?

A Look At The Fair Value Of Inari Medical, Inc. (NASDAQ:NARI)

Oct 23
A Look At The Fair Value Of Inari Medical, Inc. (NASDAQ:NARI)

Inari Medical (NASDAQ:NARI) Is In A Strong Position To Grow Its Business

Sep 18
Inari Medical (NASDAQ:NARI) Is In A Strong Position To Grow Its Business

Is Inari Medical, Inc. (NASDAQ:NARI) Potentially Undervalued?

Aug 14
Is Inari Medical, Inc. (NASDAQ:NARI) Potentially Undervalued?

Inari Medical, Inc. (NASDAQ:NARI) Shares Could Be 23% Above Their Intrinsic Value Estimate

Jul 25
Inari Medical, Inc. (NASDAQ:NARI) Shares Could Be 23% Above Their Intrinsic Value Estimate

We Think Inari Medical (NASDAQ:NARI) Can Afford To Drive Business Growth

Jun 18
We Think Inari Medical (NASDAQ:NARI) Can Afford To Drive Business Growth

Inari Medical, Inc.'s (NASDAQ:NARI) Price In Tune With Revenues

Apr 17
Inari Medical, Inc.'s (NASDAQ:NARI) Price In Tune With Revenues

Revenue & Expenses Breakdown

How Inari Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:NARI Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24574-79419104
30 Jun 24547-5739796
31 Mar 24521-2436892
31 Dec 23494-235188
30 Sep 23469-333785
30 Jun 23439-1632783
31 Mar 23413-2831580
31 Dec 22383-2929374
30 Sep 22359-2225873
30 Jun 22336-1523966
31 Mar 22306-120859
31 Dec 212771019051
30 Sep 212421616739
30 Jun 212082513432
31 Mar 211701711024
31 Dec 20140149018
30 Sep 2011177215
30 Jun 208615911
31 Mar 20714489
31 Dec 1951-1377
31 Dec 187-10114

Quality Earnings: NARI is currently unprofitable.

Growing Profit Margin: NARI is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: NARI is unprofitable, and losses have increased over the past 5 years at a rate of 67.9% per year.

Accelerating Growth: Unable to compare NARI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NARI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (11.7%).


Return on Equity

High ROE: NARI has a negative Return on Equity (-18.07%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies